Eindhoven-based Mantispectra has released the alpha version of its Chipsense 2.0-16, a spectral sensing chip aimed at enabling real-time material and health analysis in mass-market devices. Measuring 4 by 4 mm, the chip features 16 integrated photodetectors with multi-peak wavelength responses between 550 and 1700 nm – an essential range for chemometric analysis.
The new release marks a strategic milestone for Mantispectra, transitioning the company from a research-focused startup to a fabless semiconductor supplier. The Chipsense 2.0-16 is the first product manufactured entirely by Mantispectra’s supply chain partners. “This release enables consumer and professional solution providers to integrate real-time material analysis and health insights into disruptive products,” says CEO Maurangelo Petruzzella.
Target applications span wearables, smart home appliances and industrial quality control. The sensor’s enhanced selectivity promises detection of biomarkers previously inaccessible in wearable formats, while its spectral fingerprinting capabilities support AI-powered classification and quantification of a wide range of (bio)materials.
The Chipsense 2.0-16 is now available in limited quantities for early adopters, with full-scale production scheduled by the end of 2025. Development kits are available to help customers explore the integration into their own platforms.
